Antihistamines may offer hope for long COVID patients

(Dr. Liji Thomas/ News Medical Net) — The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused the ongoing pandemic of coronavirus disease 2019 (COVID-19), led to an enormous disruption of the global economy. Over 413 million cases of COVID-19 have been reported as of February 15, 2022, with 5.8 million deaths.

Even among those who have recovered from COVID-19, many experience post-acute sequelae of COVID-19 (PASC), which has no accepted definition or treatment. Healthcare providers, already struggling with the demands of handling the pandemic while simultaneously carrying out other urgent medical work, have little time to investigate the vague and protean manifestations of PASC, and even less to look into possible treatment avenues. (…)